Pharma Business 83 Views Enhertu approved in the EU for the treatment of HER2-positive metastatic breast cancer Malin Otmani January 21, 2021 AstraZeneca and Daiichi Sankyo have …
Pharma Business 103 Views AstraZeneca’s Imfinzi approved in the EU Malin Otmani January 19, 2021 AstraZeneca’s Imfinzi (durvalumab) has been …
Pharma Business 120 Views AstraZeneca’s Enhertu approved in the US Malin Otmani January 18, 2021 AstraZeneca and Daiichi Sankyo’s Enhertu …
Clinical Trials 161 Views Ultimovacs announces Phase II collaboration study in ovarian cancer Malin Otmani January 12, 2021 Ultimovacs will participate in the …
Pharma Business 123 Views AstraZeneca’s Farxiga granted Priority Review in the US Malin Otmani January 12, 2021 AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority …
COVID-19 185 Views AstraZeneca’s COVID-19 vaccine obtains emergency use authorization in India Malin Otmani January 7, 2021 AstraZeneca’s COVID-19 vaccine has been …
COVID-19 182 Views AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK Malin Otmani January 4, 2021 The UK Medicines and Healthcare …
Acquisition 456 Views AstraZeneca to acquire Alexion in USD 39 billion deal Malin Otmani December 14, 2020 AstraZeneca and Alexion Pharmaceuticals have …
COVID-19 419 Views Interim analysis results from AstraZeneca-Oxford Phase III trials Malin Otmani December 9, 2020 Results of an interim analysis …
Clinical Trials 245 Views AstraZeneca announces results from Calquence trial Malin Otmani December 7, 2020 Long-term follow-up results from the …
Pharma Business 270 Views AstraZeneca’s Forxiga approved in Japan for chronic heart failure Malin Otmani December 2, 2020 Forxiga (dapagliflozin) has been approved …
Acquisition 423 Views AstraZeneca divests Crestor to Grünenthal in Europe Malin Otmani December 1, 2020 AstraZeneca has agreed to sell …
Pharma Business 217 Views Imfinzi approved in the US for less-frequent, fixed-dose use Malin Otmani November 24, 2020 AstraZeneca’s Imfinzi (durvalumab) has been approved in …
Pharma Business 529 Views Calquence approved in the EU for the treatment of chronic lymphocytic leukaemia Malin Otmani November 9, 2020 AstraZeneca’s Calquence (acalabrutinib), a selective …
Pharma Business 386 Views AstraZeneca’s Lynparza approved in the EU in ovarian cancer Malin Otmani November 6, 2020 AstraZeneca and MSD’s Lynparza (olaparib) has been …
Business article 824 Views Waters establishes a team in BioVentureHub Malin Otmani November 2, 2020 Waters Corporation has established a …